{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:57Z","timestamp":1772119737870,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20200109140614667"],"award-info":[{"award-number":["JCYJ20200109140614667"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20190809101409603"],"award-info":[{"award-number":["JCYJ20190809101409603"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171676"],"award-info":[{"award-number":["82171676"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201793"],"award-info":[{"award-number":["82201793"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11046-024-00889-4","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T02:03:00Z","timestamp":1729476180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis"],"prefix":"10.1007","volume":"189","author":[{"given":"Zhansong","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2446-7487","authenticated-orcid":false,"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8672-360X","authenticated-orcid":false,"given":"Shangrong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"9577","key":"889_CR1","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","volume":"369","author":"JD Sobel","year":"2007","unstructured":"Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961\u201371.","journal-title":"Lancet"},{"issue":"6","key":"889_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","volume":"42","author":"B Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905\u201327.","journal-title":"Crit Rev Microbiol"},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2217\/fmb-2021-0173","volume":"16","author":"JD Sobel","year":"2021","unstructured":"Sobel JD, Nyirjesy P. Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis. Fut Microbiol. 2021;16:1453\u201361.","journal-title":"Fut Microbiol"},{"issue":"11","key":"889_CR4","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339\u201347.","journal-title":"Lancet Infect Dis"},{"key":"889_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.816161","volume":"12","author":"Z Dong","year":"2022","unstructured":"Dong Z, Fan C, Hou W, Rui C, Wang X, Fan Y, et al. Vaginal exposure to Candida albicans during early gestation results in adverse pregnancy outcomes via inhibiting placental development. Front Microbiol. 2022;12: 816161.","journal-title":"Front Microbiol"},{"issue":"2","key":"889_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11095-022-03441-5","volume":"40","author":"J Conte","year":"2023","unstructured":"Conte J, Parize AL, Caon T. Advanced solid formulations for vulvovaginal candidiasis. Pharm Res. 2023;40(2):593\u2013610.","journal-title":"Pharm Res"},{"issue":"10","key":"889_CR7","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.4103\/0366-6999.181964","volume":"129","author":"FJ Wang","year":"2016","unstructured":"Wang FJ, Zhang D, Liu ZH, Wu WX, Bai HH, Dong HY. Species distribution and in vitro antifungal susceptibility of vulvovaginal candida isolates in China. Chin Med J. 2016;129(10):1161\u20135.","journal-title":"Chin Med J"},{"issue":"1\u20132","key":"889_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11046-022-00687-w","volume":"188","author":"S Kan","year":"2023","unstructured":"Kan S, Song N, Pang Q, Mei H, Zheng H, Li D, et al. In vitro antifungal activity of azoles and other antifungal agents against pathogenic yeasts from vulvovaginal candidiasis in China. Mycopathologia. 2023;188(1\u20132):99\u2013109.","journal-title":"Mycopathologia"},{"issue":"7","key":"889_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/myc.13582","volume":"66","author":"JD Sobel","year":"2023","unstructured":"Sobel JD, Sebastian S, Boikov DA. A longitudinal study on fluconazole resistance in Candida albicans vaginal isolates. Mycoses. 2023;66(7):563\u20135.","journal-title":"Mycoses"},{"issue":"6","key":"889_CR10","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/AOG.0b013e31827307b2","volume":"120","author":"D Marchaim","year":"2012","unstructured":"Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. Fluconazole-resistant Candida albicans vulvovaginitis. Obstet Gynecol. 2012;120(6):1407\u201314.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"889_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1\u2013187.","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"889_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1067\/mob.2001.115116","volume":"185","author":"JD Sobel","year":"2001","unstructured":"Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol. 2001;185(2):363\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"889_CR13","doi-asserted-by":"crossref","unstructured":"Wang X, Wang W, Li J, An R, Chen L, Lin J, et al. Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind study. Infection. 2024; 3.","DOI":"10.1007\/s15010-024-02233-w"},{"issue":"4","key":"889_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1-50.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"889_CR15","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/AOG.0000000000003857","volume":"135","author":"JA Paavonen","year":"2020","unstructured":"Paavonen JA, Brunham RC. Vaginitis in nonpregnant patients: ACOG practice bulletin number 215. Obstet Gynecol. 2020;135(5):1229\u201330.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"889_CR16","first-page":"36","volume":"68","author":"JM Tobin","year":"1992","unstructured":"Tobin JM, Loo P, Granger SE. Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Genitourin Med. 1992;68(1):36\u20138.","journal-title":"Genitourin Med"},{"issue":"1","key":"889_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1128\/AAC.37.1.89","volume":"37","author":"GE Stein","year":"1993","unstructured":"Stein GE, Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob Agents Chemother. 1993;37(1):89\u201392.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"889_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000371759","volume":"80","author":"S Fan","year":"2015","unstructured":"Fan S, Liu X, Liang Y. Miconazole nitrate vaginal suppository 1200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis. Gynecol Obstet Invest. 2015;80(2):113\u20138.","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"889_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/mmy\/myv017","volume":"53","author":"T Li","year":"2015","unstructured":"Li T, Zhu Y, Fan S, Liu X, Xu H, Liang Y. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis. Med Mycol. 2015;53(5):455\u201361.","journal-title":"Med Mycol"},{"issue":"1\u20132","key":"889_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11046-014-9827-4","volume":"179","author":"S Fan","year":"2015","unstructured":"Fan S, Liu X, Wu C, Xu L, Li J. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. Mycopathologia. 2015;179(1\u20132):95\u2013101.","journal-title":"Mycopathologia"},{"issue":"1","key":"889_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/LGT.0000000000000126","volume":"20","author":"AM Powell","year":"2016","unstructured":"Powell AM, Gracely E, Nyirjesy P. Non-albicans Candida Vulvovaginitis: treatment experience at a tertiary care vaginitis center. J Low Genit Tract Dis. 2016;20(1):85\u20139.","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"889_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jiph.2011.05.006","volume":"4","author":"L Sekhavat","year":"2011","unstructured":"Sekhavat L, Tabatabaii A, Tezerjani FZ. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. J Infect Public Health. 2011;4(4):195\u20139.","journal-title":"J Infect Public Health"},{"issue":"7","key":"889_CR23","doi-asserted-by":"publisher","first-page":"e1518","DOI":"10.1093\/cid\/ciaa1204","volume":"73","author":"SR Brand","year":"2021","unstructured":"Brand SR, Sobel JD, Nyirjesy P, Ghannoum MA, Schotzinger RJ, Degenhardt TP. A randomized phase 2 study of VT-1161 for the treatment of acute vulvovaginal candidiasis. Clin Infect Dis. 2021;73(7):e1518\u201324.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"889_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.mayocp.2021.09.022","volume":"97","author":"ML Marnach","year":"2022","unstructured":"Marnach ML, Wygant JN, Casey PM. Evaluation and management of vaginitis. Mayo Clin Proc. 2022;97(2):347\u201358.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"889_CR25","first-page":"CD002845","volume":"8","author":"HJ Denison","year":"2020","unstructured":"Denison HJ, Worswick J, Bond CM, Grimshaw JM, Mayhew A, Gnani RS. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 2020;8(8):CD002845.","journal-title":"Cochrane Database Syst Rev"},{"key":"889_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.addr.2015.06.008","volume":"92","author":"R Palmeira-de-Oliveira","year":"2015","unstructured":"Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, Martinez-de-Oliveira J. New strategies for local treatment of vaginal infections. Adv Drug Deliv Rev. 2015;92:105\u201322.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"889_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/myc.12485","volume":"59","author":"X Zhou","year":"2016","unstructured":"Zhou X, Li T, Fan S, Zhu Y, Liu X, Guo X, et al. The efficacy and safety of clotrimazole vaginal tablet vs oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses. 2016;59(7):419\u201328.","journal-title":"Mycoses"},{"key":"889_CR28","doi-asserted-by":"publisher","first-page":"205031212210854","DOI":"10.1177\/20503121221085437","volume":"10","author":"L Zhang","year":"2022","unstructured":"Zhang L, De Salvo R, Ehret A, Young K, Trapp S. Vulvovaginal candidiasis: a real-world evidence study of the perceived benefits of Canesten\u00ae. SAGE Open Med. 2022;10:20503121221085436.","journal-title":"SAGE Open Med"},{"issue":"7","key":"889_CR29","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/jog.15267","volume":"48","author":"L Jafarzadeh","year":"2022","unstructured":"Jafarzadeh L, Ranjbar M, Nazari T, Naeimi Eshkaleti M, Aghaei Gharehbolagh S, Sobel JD, et al. Vulvovaginal candidiasis: an overview of mycological, clinical, and immunological aspects. J Obstet Gynaecol Res. 2022;48(7):1546\u201360.","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"889_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijgo.2007.03.017","volume":"97","author":"SR Fan","year":"2007","unstructured":"Fan SR, Liu XP. In vitro miconazole susceptibility and clinical outcome in vulvovaginal candidiasis. Int J Gynaecol Obstet. 2007;97(3):207\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"889_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1439-0507.2010.01887.x","volume":"54","author":"SR Fan","year":"2011","unstructured":"Fan SR, Liu XP. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. Mycoses. 2011;54(6):501\u20135.","journal-title":"Mycoses"},{"key":"889_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.110756","volume":"111","author":"HS Sofi","year":"2020","unstructured":"Sofi HS, Abdal-Hay A, Ivanovski S, Zhang YS, Sheikh FA. Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: current status and future perspectives. Mater Sci Eng C Mater Biol Appl. 2020;111: 110756.","journal-title":"Mater Sci Eng C Mater Biol Appl"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-024-00889-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T22:02:33Z","timestamp":1733004153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-024-00889-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1007\/s11046-024-00889-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4511813\/v1","asserted-by":"object"}]},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"93"}}